Background: Point-of-injury extended focused assessment with sonography in trauma (eFAST) may identify life-threatening torso hemorrhage and expedite casualty evacuation. The purpose of this study was to compare combat medic eFAST performance between the novel and conventional ultrasound (US) transducers.

Methods: We conducted a randomized crossover trial. Medic participants, previously naïve to US, were randomized to the type of transducer first utilized. The primary outcome was eFAST completion time in seconds. Secondary outcomes included diagnostic accuracy, technical adequacy, and transducer ease-of-use rating.

Results: Forty medics performed 160 eFASTs. We found a statistically significant difference in eFAST completion times in favor of conventional transducers (304 vs. 358 s; P = 0.03). There was no statistically significant difference between the conventional and novel transducers in terms of diagnostic accuracy (97.7% vs. 96.0%; P = 0.25) and technical adequacy (65% vs. 72.5%; P = 0.11). Median transducer ease-of-use rating (Likert 1-5 scale) was statistically significant in favor of the conventional transducers (5 vs. 4; P = < 0.001).

Conclusions: Extended focused assessment with sonography in trauma exam times was faster with the conventional transducers. Combat medics performed diagnostically accurate eFASTs with both transducer types in a simulated aid station setting after a brief training intervention. Conventional transducers were rated higher for ease-of-use.

Download full-text PDF

Source
http://dx.doi.org/10.1093/milmed/usz277DOI Listing

Publication Analysis

Top Keywords

conventional transducers
12
combat medic
8
medic efast
8
efast performance
8
performance novel
8
randomized crossover
8
crossover trial
8
efast completion
8
diagnostic accuracy
8
technical adequacy
8

Similar Publications

Study on a Strategy to Improve the Image Quality and Imaging Depth for Novel Synthetic Aperture Schemes: An Experimental Investigation.

Ultrason Imaging

January 2025

Biomedical Ultrasound Imaging Laboratory, Department of Applied Mechanics and Biomedical Engineering, Indian Institute of Technology, Madras, Chennai, India.

Imaging depth remains a restriction for Synthetic Aperture (SA) approaches, even though SA techniques have been shown to overcome some of the drawbacks of Conventional Focused Beamforming (CFB) technique. This limitation is attributed to lesser energy per transmit in SA techniques compared to that of CFB technique. Therefore, in this paper, a systematic investigation is done to evaluate the improvement in imaging depth and image quality of B-mode ultrasound images in the case of SA technique using PZT transducer by boosting the input voltage to the transducer, while measuring the acoustic exposure parameters recommended in international standards.

View Article and Find Full Text PDF

An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment.

Mater Today Bio

February 2025

Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.

Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related deaths. In this study, we propose a novel esophageal stent equipped with a wireless, battery-free, and movable photodynamic therapy (PDT) unit designed to treat esophageal tumors with flexibility, precision, and real-time control. This system integrates a PDT unit and an electrochemical pneumatic soft actuator into a conventional esophageal stent.

View Article and Find Full Text PDF

Quantification of L-lactic acid in human plasma samples using Ni-based electrodes and machine learning approach.

Talanta

December 2024

NanoBiosensors and Biodevices Lab, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, 721302, India. Electronic address:

This work presents a robust strategy for quantifying overlapping electrochemical signatures originating from complex mixtures and real human plasma samples using nickel-based electrochemical sensors and machine learning (ML). This strategy enables the detection of a panel of analytes without being limited by the selectivity of the transducer material and leaving accommodation of interference analysis to ML models. Here, we fabricated a non-enzymatic electrochemical sensor for L-lactic acid detection in complex mixtures and human plasma samples using nickel oxide (NiO) nanoparticle-modified glassy carbon electrodes (GCE).

View Article and Find Full Text PDF

Target-assisted self-powered photoelectrochemical sensor based on AgS/BiOCl heterojunction for ultrasensitive chlorpyrifos detection.

Talanta

December 2024

College of Geography and Environmental Sciences, College of Chemistry and Materials Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, Zhejiang Normal University, Jinhua, 321004, China. Electronic address:

Chlorpyrifos (CPF), a widely used organophosphorus pesticide, presents substantial risks to both environmental and human health due to its persistent accumulation, thereby necessitating the development of effective detection methods. Self-powered photoelectrochemical (PEC) sensors, as an innovative technology, address the limitations inherent in conventional sensors, such as susceptibility to interference and inadequate signal response. Herein, we synthesized AgS/BiOCl as a photosensitive material, employing it as a light-harvesting substrate and a signal-transducing platform to develop a self-powered PEC sensor for the detection of CPF.

View Article and Find Full Text PDF

ErbB3 is markedly overexpressed in breast cancer cells and is associated with resistance and metastasis. Additionally, ErbB3 expression levels are positively correlated with low densities of tumor-infiltrating lymphocytes, a marker of poor prognosis. Consequently, ErbB3 is a promising therapeutic target for cancer immunotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!